Table 1.
Baseline Characteristics
| Total n = 98 | |
|---|---|
| Age years (mean ± SD) | 59.1 ± 10 |
| Male gender; n (%) | 86 (87.7%) |
| Cardiovascular risk factors n (%) | |
| Dyslipidemia | 76 (77.5) |
| Diabetes | 63 (64.3) |
| Arterial hypertension | 61 (62.2) |
| Smoking | 58 (59.2) |
| Coronary artery disease | 48 (48.9) |
| Number | |
| 2 | 60 (61.2) |
| 3 | 27 (27.5) |
| ≥ 4 | 11 (11.3) |
| Treatment n (%) | |
| Aspirin | 90 (91.8) |
| Statins | 81 (82.6) |
| Oral antidiabetics | 63 (64.2) |
| Enzyme converting inhibitors | 59 (60.2) |
| Beta-blockers | 42 (42.8) |
| Diuretics | 20 (20.4) |
| Angiotension receptor antagonists | 12 (12.2) |
| Vitamin K antagonists | 5 (4.9) |
| Clopidogrel indications | |
| Coronary artery disease | 90 (91.8) |
| Peripheral artery disease | 8 (8.2) |